CHEMISTRY WORLD | It’s been almost 10 years since the World Health Organization warned of a post-antibiotic era unless action was taken against the growing risk of antibiotic resistance. There has been some progress in investment in the development of new approaches to address the most serious drug-resistant bacteria. CARB-X and the AMR Action Fund are positive steps toward supporting the development of innovative products to address the emerging and growing threat of superbugs. World leaders are beginning to look at policy changes that would remove the economic obstacles to new product development. Yet, 700,000 people die each year from antibiotic-resistant infections and antibiotic resistance continues to spread and thrive. The central question remains. Will this threat be solved before it mushrooms into an even bigger public health crisis?